Complement and microglia mediate early synapse loss in Alzheimer mouse models
Open accessThe DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index; 21 of the 28 sources its claims cite were checked for support.
Abstract
Too much cleaning up: The complement system and microglia seek out and destroy unwanted cellular debris for the peripheral immune system as well as excess synapses in the developing brain. Hong et al. now show how the system may go haywire in adults early in the progression toward Alzheimer's disease (AD). Aberrant synapse loss is an early feature of Alzheimer's and correlates with cognitive decline. In mice susceptible to AD, complement was associated with synapses, and microglial function was required for synapse loss. The authors speculate that aberrant activation of this “trash disposal” system underlies AD pathology. Science , this issue p. 712
Overview
CoChat Summary
TL;DR
In Alzheimer mouse models, classical complement proteins C1q and C3 increase and localize to synapses before plaques, and blocking C1q, C3, or microglial CR3 reduces early synapse loss. Soluble Aβ oligomers drive microglial engulfment of synaptic material through a CR3-dependent pathway, suggesting reactivation of developmental synaptic pruning in early AD.
Key findings
- J20 hAPP mice showed significant hippocampal synapse loss at 3–4 months, before plaque deposition; loss occurred in CA1, CA3, and dentate gyrus at 3 months but not in striatum, and was not seen at 1 month.
- C1q was elevated in J20 brains as early as 1 month, region-specifically in hippocampus and frontal cortex, and colocalized with PSD95-positive puncta; Compound E reduced soluble Aβ and C1q deposition, while oligomeric Aβ—but not monomeric Aβ or vehicle—induced C1q deposition and synaptic colocalization.
- Oligomeric Aβ induced synapse loss within 72 h in WT mice but not in C1qa knockout mice; anti-C1q antibody ANX-M1 prevented oAβ-induced synapse loss and LTP impairment, and APP/PS1xC3 KO mice did not show the synapse loss seen in 4-month APP/PS1 hippocampus.
- Microglial CD68 increased in J20 hippocampus and after oAβ; oAβ increased internalized Homer-GFP in microglia, failed to do so in CR3 KO mice, and induced hippocampal synapse loss in WT but not CR3 KO mice.
Methods
- Mouse models included J20 hAPP, APP/PS1, C1qa KO, C3 KO, CR3 KO, and Homer-GFP mice, with WT littermates and ages including 1 month, 3–4 months, and P21.
- Synapse quantification used super-resolution structured illumination microscopy, confocal imaging, and electron microscopy with colocalized pre- and postsynaptic puncta markers including synaptophysin/PSD95, synaptotagmin/homer, and synapsin/PSD95; C1q and C3 colocalization with PSD95 was also measured.
- Interventions included Compound E, intracerebroventricular or tail vein injections of soluble Aβ oligomers, monomers, or vehicle, anti-C1q antibody ANX-M1 or IgG control, acute hippocampal slice LTP recordings, and an in vivo synaptic engulfment assay.
Limitations
- The paper states that specific synaptic C1q receptors are not yet known and that oAβ and C1q may act indirectly through cytokines such as TGFβ, microglial or astrocytic activation, or other pathways including MHCI/PirB.
- The paper states that the complement pathway may not be involved in all pathological routes to AD, including plaque-associated synapse loss, and that future studies are needed to examine plaque-associated synapse loss and other synaptopathies such as tauopathies and Huntington’s disease.
- Evident from the text: the findings are from mouse models and acute hippocampal slices, not human AD tissue or clinical trials, and the study focuses on early pre-plaque mechanisms rather than established plaque-associated neuropathology.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
16 Valid · 0 Not valid · 2 Not checked · 48 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“C1q binds synapses in vulnerable regions undergoing synapse loss (our data here; (5, 27)).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [5] Stevens B The classical complement cascade mediates CNS synapse elimination. Cell 2007 131 1164 1178 18083105 source
The Results report C1q localized to synapses in the developing dLGN during synaptic pruning and relocalized to adult retinal synapses in early glaucoma, before significant synapse loss. The Discussion likewise places synaptic C1q relocalization before or concurrent with synapse loss in the glaucoma model. (LLM, conf=0.89)
- Not checked — no full text of the sourcecites [27] Stephan AH Barres BA Stevens B The complement system: an unexpected role in synaptic pruning during development and disease. Annu. Rev. Neurosci 2012 35 369 389 22715882 source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“suggesting that the engulfed synapses are internalized into lysosomal compartments in a manner similar to developmental synaptic pruning (6).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [6] Schafer DP Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner. Neuron 2012 74 691 705 22632727 PMC3528177 source
The Results section, “Microglia engulf RGC inputs during a period of active synaptic pruning” (page unavailable), reports that most engulfed RGC inputs colocalized with microglial lysosomal compartments. The Results section, “Microglia engulf presynaptic elements specific to RGCs” (page unavailable), also identifies an RGC presynaptic marker within microglial lysosomes, supporting the proposed similarity to developmental synaptic pruning. (LLM, conf=0.94)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Quantification of colocalized pre- and postsynaptic puncta (synaptophysin and PSD95 (Fig. 1A); synaptotagmin and homer (figs. S1A-D)) revealed a significant loss of synapses in J20 hippocampus at 3-4 months old (mo), an age that precedes plaque deposition (11, 12).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [11] Mucke L High-Level Neuronal Expression of Abeta 1-42 in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation. Journal of Neuroscience 2000 20 4050 10818140 PMC6772621 source
The citation is attached to the statement that 3–4 months precedes plaque deposition, not to the citing authors’ synapse measurements. In “Effects of hAPP mutations on formation of amyloid plaques” (Fig. 4; page not provided), the paper assesses mice at 2–4 months and reports amyloid deposition in APP Sw,Ind mice at 5–7 months; the paper identifies J20 as an APP Sw,Ind line. (LLM, conf=0.91)
- Supportedcites [12] Hong S Dynamic Analysis of Amyloid -Protein in Behaving Mice Reveals Opposing Changes in ISF versus Parenchymal A during Age-Related Plaque Formation. Journal of Neuroscience 2011 31 15861 15869 22049429 PMC3227224 source
The citation follows the statement that 3–4 months precedes plaque deposition, rather than the citing authors’ own synapse measurements. The Results section (page unavailable) identifies approximately 3-month-old J20 mice as pre-plaque and describes 3–7-month-old mice as plaque-free. (LLM, conf=0.91)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Genome-wide association studies (GWAS) implicate microglia and complement-related pathways in AD (1).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [1] Hong S Dissing-Olesen L Stevens B New insights on the role of microglia in synaptic pruning in health and disease. Curr Opin Neurobiol 2016 doi:10.1016/j.conb.2015.12.004 PMC5479435 26745839 source
The Introduction says GWAS and integrated network studies identify immune-related AD risk pathways implicating microglia. The section on microglia–synapse dysfunction identifies GWAS variants CLU and CR1, both related to complement. Page numbers are not provided in our copy. (LLM, conf=0.93)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“C1q was also similarly increased in hippocampus of another model of AD, the APP/PS1 mice (15) (Fig. S2C).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [15] Jankowsky JL Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum. Mol. Genet 2004 13 159 170 14645205 source
The citation identifies the APP/PS1 mouse model, while the citing document points to its own Fig. S2C for the C1q increase. Figure 2 (p. 4) describes APPswe/PS1 double-transgenic mice and shows hippocampal amyloid pathology in that model. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
48 more claims · 5 with their cited sources checked
Create a free account to see all 66 claims and every source verdict.
- It may state two separate claims as one. 11
- Probably not a substantial claim. 2
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“increasing evidence demonstrate that immune signaling may not just be a consequence of protein aggregation in the brain, but that it actually causes the buildup of aggregates at the earliest stages of the disease process.15–17”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [15]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In neurodegeneration, the complement pathway is activated, and inhibiting the complement proteins C1q or C3 results in less neuroinflammation, Aβ plaques and synapse loss29,30.”
From Exercise plasma boosts memory and dampens brain inflammation via clusterin (2021) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Before the onset of Aβ deposition, microglia engulf synapses opsonized with the complement factors C1q and C3 upon CR3-mediated recognition of C3 (121).”
From Microglia in Alzheimer's disease (2017) · cites this paper as [121]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Lack of C1q, C3, or CR3 curbed microglia activation and synaptic loss during amyloid plaque deposition.”
From Microglia Function in the Central Nervous System During Health and Neurodegeneration (2017) · cites this paper as [139]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Inappropriate control of the classical complement cascade causes unresolvable inflammation and disease (Hong et al. , 2016; Hansen, Hanson and Sheng, 2018; Morgan, 2018).”
From Spatial Transcriptomics and In Situ Sequencing to Study Alzheimer’s Disease (2020) · cites this paper as Hong et al., 2016
Experimental — accuracy not yet measured
70 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Self-check results appear here once an independent check has confirmed them.
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
In the paper
“It is also plausible that oAβ and C1q may work indirectly to mediate synapse loss through cytokines such as TGFβ (7), through microglial or astrocytic activation, or through other mechanisms including MHCI/PirB, another immune pathway critical for synapse elimination in development and AD (28-30).”
Cited work 10.1038/nn.3560 · retracted 2022-01-13 · notice 10.1038/s41593-021-00877-7 · this paper published 2016-05-06
Citations
Cites
1 retracted
Bialas, A. R., & Stevens, B. (2013) · Nature Neuroscience · doi:10.1038/nn.3560 · Cited by 519 · cited 2×
“It is also plausible that oAβ and C1q may work indirectly to mediate synapse loss through cytokines such as TGFβ (7), through microglial or astrocytic activation, or through other mechanisms including MHCI/PirB, another immune pathway critical for synapse elimination in development and AD (28-30).”
Self-citationRetractedAmyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420 · cited 1×
“Synaptic deficits occur in early AD and mild cognitively impaired patients before onset of plaques and are some of the first signs of the neuronal degenerative process (4, 23-25).”
Self-citationTerry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397 · cited 1×
“The degree of region-specific synapse loss is a stronger correlate of cognitive decline in AD than counts of plaques, tangles and neuronal loss (8, 9).”
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089
Self-citationThe Classical Complement Cascade Mediates CNS Synapse Elimination
Stevens, B., Allen, N. J., Vazquez, L. E., Howell, G. R., Christopherson, K. S., Nouri, N., Micheva, K. D., Mehalow, A. K., Huberman, A. D., Stafford, B., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.036 · Cited by 3,313 · cited 4×
“Although specific receptors for C1q at synapses are not yet known, C1q binds synapses in vulnerable regions undergoing synapse loss (our data here; (5, 27)).”
InfluentialSelf-citationIdentification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543 · cited 1×
“S11), indicating they are resident cells (22).”
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376 · cited 1×
“The degree of region-specific synapse loss is a stronger correlate of cognitive decline in AD than counts of plaques, tangles and neuronal loss (8, 9).”
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856 · cited 3×
“S4), long before Aβ plaques deposit (11, 12), raising the question of whether C1q increase in these pre-plaque brains is dependent on soluble Aβ levels.”
Jankowsky, J. L., Fadale, D. J., Anderson, J., Xu, G. M., Gonzales, V., Jenkins, N. A., Copeland, N. G., Lee, M. K., Younkin, L. H., Wagner, S. L., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh019 · Cited by 1,575
Cited by
Items 2,701–2,800 of 3,349
Microglia regulate cognition and stress-related cognitive disorders
Zhou, M., Salinas, S., Cornell, J. L., & Bui, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-817558-3.00014-7 · Cited by 1
Methyl vinyl ketone impairs spatial memory and activates hippocampal glial cells in mice
Sato, R. Y., Kotake, K. T., Zhang, Y., Onishi, H., Matsui, F., Norimoto, H., & Zhou, Z. (2023) · PLoS ONE · doi:10.1371/journal.pone.0289714 · Cited by 1
“Similarly, activated microglia are known to eliminate synapses through the complement pathway, which causes memory deficits [23, 24].”
BackgroundKhachaturian, A. S., & Khachaturian, Z. S. (2023) · Care weekly · doi:10.14283/vme.2023.2 · Cited by 5
Dutta, D., Tripathi, D., Asthana, P., Rana, K., Jain, N., Sharma, R., Naithani, U., Jauhari, D., & Rachana, R. (2024) · Springer eBooks · doi:10.1007/978-981-99-7779-6_23 · Cited by 1
Quantification of Microglial Engulfment of Synaptic Material Using Flow Cytometry
Ugursu, B., & Wolf, S. A. (2024) · Journal of Visualized Experiments · doi:10.3791/66639 · Cited by 2
Potential prognostic value of CSF-targeted proteomics across the Alzheimer’s disease continuum
Xu, B., Ling, Y., Liu, L., Liu, Y., Lin, Y., Lyu, J., & Zhang, Y. (2024) · BMC Geriatrics · doi:10.1186/s12877-024-05104-z · Cited by 2
“Furthermore, C1q participates in the toxicity induced by soluble Aβ oligomers on synapses and long-term potentiation in the hippocampus [29], while reduced expression of NPTX2 activates complement C1q, leading to neurotox-icity, which may be one of the mechanisms contributing to cortical atrophy…”
BackgroundDevelopmental and age-related synapse elimination is mediated by glial Croquemort
Jay, T. R., Kang, Y., Ouellet-Massicotte, V., Micael, M. K. B., Kacouros-Perkins, V. L., Chen, J., Sheehan, A. E., & Freeman, M. R. (2026) · Neuron · doi:10.1016/j.neuron.2026.04.046 · Cited by 1
Contactomics of Microglia and Intercellular Communication
Cserép, C., Pósfai, B., Szabadits, E., & Dénes, Á. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-55529-9_8 · Cited by 2
Rao, S., Yung, J., Edick, M. G., & Hanson, J. E. (2024) · STAR Protocols · doi:10.1016/j.xpro.2024.103388 · Cited by 2
Neurotrophins: Decades of Discoveries
Mocchetti, I., & Speidell, A. P. (2024) · Springer eBooks · doi:10.1007/978-3-031-68237-7_17 · Cited by 1
Mätlik, K., Pressl, C., & Heintz, N. (2025) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-112723-025516 · Cited by 1
Risen, S. J., Wahl, D., LaRocca, T. J., & Moreno, J. A. (2025) · Neuroglia · doi:10.3390/neuroglia6020022 · Cited by 1
“Reactive astrocytes and microglia upregulate the expression and secretion of various complement components, particularly C1q, C3, and C4, which tag vulnerable synapses for elimination [292].”
AXL-mediate GEF-H1 phosphorylation was involved in microglia synapse phagocytosis in 5xFAD mice
Chen, G., Zhang, J., Dong, A., Xiao, L., Huang, P., Huang, T., Ye, Q., & Huang, E. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115327 · Cited by 1
Sun, J., Shao, X., Wang, X. L., Yin, X., Qiu, W., Qian, X., Liu, F., Chen, Y., & Ma, C. (2025) · Molecular Brain · doi:10.1186/s13041-025-01226-6 · Cited by 4
“Microglial C1Q can upregulate its expression in response to pathological AD proteins, enhancing microglial phagocytosis and exacerbating synaptic loss in amyloid mouse models [39, 40].”
Al-Alwan, L. A., Clément, J.-P., Fisher, T. A. J., Braatz, D., Chitsaz, D., Mohammadifar, E., Hudziak, C., Hellmund, M., Mauzeroll, J., Haag, R., et al. (2025) · ACS Nano · doi:10.1021/acsnano.5c04077 · Cited by 2
The Impact of Ultrasound on APP/PS1 Model Mouse
Li, L., Wang, W., Wu, W., Zhang, W., Gao, Y., & Chen, C. (2017) · International Conference on Material Science, Energy and Environmental Engineering (MSEEE) · doi:10.2991/mseee-17.2017.36 · Cited by 1
“Clinical imaging and neuropathological studies have shown that microglia in the central nervous system can maintain the normal physiological activity of the brain, and the activated microglia can protect the central nervous system [22].”
BackgroundMicroglia and cellular differentiation — possibility of microglia as drug discovery target
Shigemoto‐Mogami, Y., & Sato, K. (2017) · Folia Pharmacologica Japonica · doi:10.1254/fpj.150.268 · Cited by 1
Alzheimer’s Disease: Beyond the Neuron
Verma, A., & Zabel, M. K. (2018) · InTech eBooks · doi:10.5772/intechopen.75510 · Cited by 1
“Microglia then eliminated these C1q- or C3b-tagged synapses, leading to neurodegeneration and behavioral impairment [17, 18].”
BackgroundVillani, A., & Peri, F. (2019) · Developmental Cell · doi:10.1016/j.devcel.2018.12.013 · Cited by 3
Xavier, A. M., Belhocine, S., & Gosselin, D. (2019) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1449 · Cited by 1
“Alternatively, inflammatory microglia may be more prone to engage in excessive interactions with neuronal synapses and may thus destabilize neuronal circuitries (Hong et al., 2016).”
BackgroundThe dark side of antiviral T cell responses
Krukowski, K., & Rosi, S. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0454-8 · Cited by 1
Inflammation and insulin resistance in Alzheimer’s disease
Nash, Y., & Frenkel, D. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815868-5.00025-6 · Cited by 1
PREBIOTICS FOR ACUTE ISCHEMIC STROKE
Renamastika, S. N., Wahyuningrum, D. R., PUTRI, V. A., & Aisy, R. (2021) · International Journal of Pharmacy and Pharmaceutical Sciences · doi:10.22159/ijpps.2021v13i5.41110 · Cited by 1
Regulation of Microglia for the Treatment of Glioma
Zhou, S., & Cisse, B. (2021) · World Neurosurgery · doi:10.1016/j.wneu.2021.06.107 · Cited by 2
Microglia and macrophages in central nervous systems
Cho, I. K. H. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-822368-0.00008-6 · Cited by 3
Microglial regulation of brain function and pathological changes
Wake, H., Hashimoto, A., Kato, D., & Takeda, I. (2023) · Folia Pharmacologica Japonica · doi:10.1254/fpj.23010 · Cited by 1
Innate immune mechanisms mediate loss of corticostriatal synapses in Huntington’s disease
(2023) · Nature Medicine · doi:10.1038/s41591-023-02616-w · Cited by 1
Beckman, D., Donis‐Cox, K., Ott, S. P., Roberts, M. A., Novik, L., Janssen, W. G. M., Bliss‐Moreau, E., Rudebeck, P. H., Baxter, M. G., & Morrison, J. H. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/251025 · Cited by 1
A novel role for macrophages in peripheral nerve regeneration
Emmenis, L. V. (2018) · UCL Discovery (University College London) · Cited by 1
Sleep regulates the glial engulfment receptor Draper to promote Wallerian degenerationPreprint
Stahl, B. A., Jaggard, J. B., & Keene, A. C. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/716894 · Cited by 1
Localized calcium accumulations prime synapses for phagocyte removal in cortical neuroinflammationPreprint
Jafari, M., Schumacher, A.-M., Snaidero, N., Neziraj, T., Gavilanes, E. M. U., Jürgens, T., Weidinger, J. D. F., Schmidt, S. S., Beltrán, E., Hagan, N., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/758193 · Cited by 1
“…is also a hallmark of other neurodegenerative, neuroinfectious and neuropsychiatric disorders (Bialas et al., 2017; Di Liberto et al., 2018; Hong et al., 2016; Olmos-Alonso et al., 2016; Vasek et al., 2016), which stresses the unity of destructive mechanisms shared across a broad range of…”
BackgroundA Developmental Role for Microglial Presenilin 1 in MemoryPreprint
Ledo, J. H., Azevedo, E. P., Medrihan, L., Cheng, J., Silva, H. M., McCabe, K. A., Bamkole, M. A., Lafaille, J. J., Friedman, J. M., Stevens, B., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.26.428181 · Cited by 1
Self-citationA CRISPR/Cas9 Based Strategy to Manipulate the Alzheimerrs Amyloid PathwayPreprint
Sun, J., Carlson-Stevermer, J., Das, U., Shen, M., Delenclos, M., Snead, A. M., Wang, L., Loi, J., Petersen, A. J., Stockton, M. E., et al. (2018) · SSRN Electronic Journal · doi:10.2139/ssrn.3188478 · Cited by 1
Microglia and Fn14 regulate transcription and chromatin accessibility in developing neuronsPreprint
Ferro, A., Vrudhula, U., Auguste, Y. S. S., & Cheadle, L. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.16.456505 · Cited by 1
Ding, L., Chu, W., Xia, Y., Li, T., Ming, S., Zhou, F., & Deng, Y. (2021) · Research Square · doi:10.21203/rs.3.rs-929998/v1 · Cited by 1
Single-cell analysis of microglial transcriptomic diversity in subarachnoid hemorrhagePreprint
Chen, J., Sun, L., Lyu, H., Zheng, Z. V., Lai, H., Wang, Y., Luo, Y., Lü, G., Chan, W., Zhang, Y., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.27.474223 · Cited by 1
Jin, M., Xu, R., Wang, L., Alam, M. M., Ma, Z., Zhu, S., Martini, A. C., Jadali, A., Bernabucci, M., Xie, P., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.22.473858 · Cited by 1
Aghaizu, N. D., Jolly, S., Samra, S. K., Kalmár, B., Craessaerts, K., Greensmith, L., Salinas, P. C., Strooper, B. D., & Whiting, P. J. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.05.490649 · Cited by 1
Cardoso, F. D. S., Mansur, F., Araújo, B., Gonzalez-Lima, F., & da Silva, S. G. (2021) · Research Square · doi:10.21203/rs.3.rs-293139/v1 · Cited by 3
Fontes-Dantas, F. L., Fernandes, G. G., Gutman, E. G., de Lima, E. V., Antonio, L. S., Hämmerle, M. B., Mota-Araujo, H. P., Colodeti, L. C., Araújo, S. M. B., da Silva, T. N., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.07.495149 · Cited by 1
Faridar, A., Vasquez, M., Thome, A. D., Yin, Z., Xuan, H., Wang, J. H., Wen, S., Li, X., Thonhoff, J. R., Zhao, W., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1639205/v1 · Cited by 1
Dhungana, A., Becchi, S., Leake, J., Morris, G. P., Avgan, N., Balleine, B. W., Vissel, B., & Bradfield, L. A. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.07.25.501480 · Cited by 1
Ying, J., Reboreda, A., Yoshida, M., & Brandon, M. P. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.12.15.520595 · Cited by 1
Stoner, A. J., Fu, L., Nicholson, L., Zheng, C., Toyonaga, T., Spurrier, J. M., Laird, W., Cai, Z., & Strittmatter, S. M. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.02.15.528700 · Cited by 1
“PrP C is required for the localization of C1q to PSD-95 puncta Microglia-mediated phagocytosis of synapses is mediated by C1q and is implicated in AD synapse loss with complement tagging synapses for removal [19, 47, 48].”
BackgroundMicroglia Mediated Neuroinflammation: A Silent Contributor to Alzheimer’s DiseasePreprint
Ripa, J. D., & Roy, R. K. (2023) · Preprints.org · doi:10.20944/preprints202305.1673.v1
Heterogeneous complement and microglia activation mediates stress-induced synapse lossPreprint
Soteros, B. M., Tillmon, H., Wollet, M., General, J., Chin, H., Lee, J. B., Carreno, F. R., Morilak, D. A., Kim, J. H., & Sia, G.-M. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.28.546889 · Cited by 1
Azmoon, P., Mantuano, E., Poudel, B., Zampieri, C., & Gonias, S. L. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.06.561299 · Cited by 2
Vivi, E., & Benedetto, B. D. (2023) · Preprints.org · doi:10.20944/preprints202311.0117.v1 · Cited by 1
Mattei, D., Ivanov, A., Hammer, J., Ugursu, B., Schalbetter, S. M., Richetto, J., Weber‐Stadlbauer, U., Mueller, F. S., Scarborough, J., Wolf, S. A., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.17.567571 · Cited by 1
Martín‐Flores, N., Podpolny, M., McLeod, F., Workman, I., Crawford, K., Ivanov, D. K., Leonenko, G., Escott‐Price, V., & Salinas, P. C. (2023) · eLife · doi:10.7554/elife.89453.2 · Cited by 1
Inhibition of MicroRNA-129-5p Promotes Neuroinflammation and Cognitive ImpairmentPreprint
Kaurani, L., Zhou, J., Pradhan, R., Schröder, S., Burkhardt, S., Schuetz, A.-L., Delalle, I., Rizzu, P., Heutink, P., Sananbenesi, F., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-3870232/v1 · Cited by 1
Makhijani, P., Emani, R., Aguirre, C. G., Mu, W., Rane, A., Ng, J. H. Y., Valentino, T. R., Manwaring-Mueller, M., Tan, C. R., Du, H., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.01.27.573841 · Cited by 1
Complement propagates visual system pathology following traumatic brain injuryPreprint
Borucki, D. M., Rohrer, B., & Tomlinson, S. (2024) · Research Square · doi:10.21203/rs.3.rs-3970621/v1 · Cited by 1
“C3a can promote immune cell recruitment and activation via C3a receptor engagement, and membrane-bound C3 opsonins can be recognized by microglial complement receptors leading to recognition and clearance of C3 opsonized cells and material (11, 12).”
BackgroundEngulfment of viable neurons by reactive microglia in prion diseasesPreprint
Makarava, N., Safadi, T., Mychko, O., Pandit, N. P., Molesworth, K., Baiardi, S., Zhang, L., Parchi, P., & Baskakov, I. V. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.06.583759 · Cited by 1
“The CR3-dependent phagocytic pathway involves the complement factor C3b, which tags neurons and synapses, driving phagocytosis through interaction with CR3 [2, 3, 8].”
BackgroundFerro, A., Arshad, A., Boyd, L., Stanley, T., Berisha, A., Vrudhula, U., Gomez, A. M., Borniger, J. C., & Cheadle, L. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.02.587786 · Cited by 1
Sandoval, C., Lee, J., Tóth, B. I., Nagaraj, R., Schauer, S. P., Hoffman, J. C., Kollmorgen, G., Monteiro, C., Teng, E., Hanson, J. E., et al. (2024) · medRxiv · doi:10.1101/2024.04.13.24305768 · Cited by 1
Martá-Ariza, M., Leitner, D., Kanshin, E., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4469045/v1 · Cited by 1
Schroeder, S., Sakib, M. S., Krüger, D., Peña, T., Burkhardt, S., Schütz, A., Sananbenesi, F., & Fischer, A. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.14.607966 · Cited by 1
Inflammatory Signatures of Microglia in the Mouse Model of Corticosterone-Induced DepressionPreprint
Zhao, Y., Huang, Y., Cao, Y., & Yang, J. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.21.608928 · Cited by 1
“On the other hand, microglia responding to neurodegenerative insults may release various inflammatory factors and aberrantly engulf synaptic structures, leading to collateral destruction of neurocircuits and exacerbation of disease conditions [22-24].”
BackgroundMicroglia modulate cerebral blood flow and neurovascular coupling through ectonucleotidase CD39Preprint
Fu, Z., Ganesana, M., Hwang, P. H., Tan, X., Kinkaid, M. M., Sun, Y., Bian, E. J., Weybright, A., Sol‐Church, K., Eyo, U. B., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.05.622122 · Cited by 1
GPCR-targeted imaging and manipulation of homeostatic microglia in living systemsPreprint
Chandrasekharan, S. V., Chaubey, P., Khandelwal, S., Medishetti, R., Chakraborty, S., Rajaram, S., Jayakumar, K., Latua, P., Goyal, R., Gopalakrishna, R., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.01.646501 · Cited by 1
“There are a number of studies that describe the activated microglial phenotypes present in diseases such as Alzheimer's, Multiple Sclerosis (MS), Huntington's disease, stroke models, etc. 21–25 .”
Editorial: Exploring the molecular mechanisms that regulate macrophage polarization
Nelson, D. E., & Olszewski, M. A. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1599215 · Cited by 1
“This family of phagocytes, represented by a variety of different subtypes, performs tissue-speci fi c functions as diverse as maintaining surfactant homeostasis performed by alveolar macrophages in the lung (1) or synaptic pruning carried out by the brain ’ s microglial cells (2).”
SORLA upregulation suppresses global pathological effects in aged tauopathy mouse brainPreprint
Huang, H., Shi, C. H., Yang, W., Piña-Crespo, J., Bhatnagar, J., Curatolo, J., Murad, R., Shah, P. M., Campos, A. R., Houser, A. K., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.25.661599 · Cited by 1
SFRP1 drives glycolytic activation in astrocytes during neuroinflammationPreprint
Martinez-Baños, M., Miaja, P., Martín‐Bermejo, M. J., Pereyra, G., & Bovolenta, P. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.10.675368 · Cited by 2
“…state, which fosters a neurotoxic environment marked by aberrant release of proinflammatory cytokines (TNF-α , IL-1 β , IL-6), complement proteins (Hoogland et al., 2015; Hong et al., 2016) and reactive oxygen species (ROS), ultimately driving synaptic degradation and neuronal damage.”
LRRK2 regulates synaptic function through modulation of actin cytoskeletal dynamicsPreprint
Tombesi, G., Kompella, S. N., Favetta, G., Chen, C., Ornaghi, M., Zhao, Y., Morosin, E., Sevegnani, M., Lama, A., Marte, A., et al. (2025) · eLife · doi:10.7554/elife.95987.2 · Cited by 2
Arnst, N., Bedetta, M., Redolfi, N., Falzoni, S., Kachappilly, N., Tarantini, M., Basso, E., Giuliani, A. L., Sandonà, D., Virgilio, F. D., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.14.688405 · Cited by 2
Du, J. T., Chartrand, T., Jayadev, S., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.19.689368 · Cited by 1
“Surprisingly, several disease-associated microglia (DAM) complement markers were not correlated with this GEX-morphology axis, including C1qa , C1qb , C1qc , C3 , and C4b [18,11].”
Kumari, R., Bowen, C. A., Srivastava, U., Brandelli, A. D., Kumar, P., Kour, D., Malepati, S., Jang, W. E., Bromwich, M., Zeng, H., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.25.696456 · Cited by 2
Klimmt, J., Gonçalves, C. C., Montgomery, J. V., Müller, S. A., Bublitz, M., Filser, S., Paeger, L., Nuscher, B., Dannert, A., Roeber, S., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.20.699077 · Cited by 1
“C1QB is involved in synaptic pruning 80 , a developmental process thought to be aberrantly re-activated in early stages of AD 81 .”
Quach, B., Salehi, S. N., Roufegarinejad, R., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.13.705826 · Cited by 1
“Complement proteins (e.g. C1q, C3) have been implicated in synaptic pruning and early synapse loss in multiple mouse and human studies of Alzheimer’s disease (Hong et al., 2016; Shi et al., 2015) and may mediate microglial or astrocytic engulfment of synapses.”
Dammer, E. B., Afshar, S., Bian, S., Seyfried, N. T., Levey, A. I., Fortea, J., & Johnson, E. C. B. (2026) · medRxiv · doi:10.64898/2026.02.14.26346321 · Cited by 1
Lauderdale, K., Yan, Z., Mendiola, A. S., Zhang, Y., Mallen, D. D., Nambiar, P., Brady, E. S., Miller, S. R., Meza-Acevedo, R., Cabriga, B., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.01.722324 · Cited by 2
iAstrocytes model cytokine influences on complement expression and neuronal network synchronizationPreprint
Morshed, N., Demers, M., Gonzalez‐Ramos, A., Jäntti, H., Doman, J. L., D'Souza, S., Li, L., Granger, A. J., Johnson, M. B., & Stevens, B. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.04.730242 · Cited by 1
Self-citationMicroglia extract neuronal proteolytic organelles via skoupocytosisPreprint
Pepper, R. E., Griswold, J. M., Middleton-Davis, F., Syed, S., Imoto, Y., Tran, L., Park, E., Xu, Y.-K. T., Bergles, D., Buchanan, J., et al. (2026) · bioRxiv · doi:10.64898/2026.07.22.740182
“In response, microglia release extracellular vesicles that propagate aggregate seeding, also engaging in abberrant synapse elimination accelerating cognitive decline 79,80 .”
SORLA up-regulation suppresses pathological effects in aged tauopathy mouse brain
Huang, H., Shi, C. H., Yang, W., Piña-Crespo, J. C., Bhatnagar, J., Curatolo, J., Murad, R., Shah, P., Campos, A., Houser, A., et al. (2026) · Science Advances · doi:10.1126/sciadv.aed6825 · Cited by 1
“…biologically associated with synaptic function; C1q is a component of the complement pathway that accumulates at synapses to promote selective synaptic pruning during brain development ( 54 – 56 ) and mediates pathological elimination of synapses where microglia engulf or “prune” synapses ( 57 ).”
Murphy, S. M., & Husselbee, K. (2013) · Archives of Disease in Childhood · doi:10.1136/archdischild-2013-304107.191
A new organotypic model of synaptic competition reveals activity-dependent localization of C1qPreprint
Koyama, R., Wu, Y., Bialas, A. R., Thompson, A. D., Welsh, C. A., Frouin, A., Chen, C., & Stevens, B. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/118646
“To gain temporal control and manipulate C1q solely during the period of synaptic competition in vitro, we used a specific C1q function blocking antibody, ANX-M1 (Annexon Biosciences), which has been shown to neutralize C1q activation of the classical complement cascade (Hong et al., 2016).”
BackgroundMethodInfluentialSelf-citationComplement-mediated microglial priming : an in vitro study
Wheat, R. (2016) · ORCA Online Research @Cardiff (Cardiff University)
Mikroglia – Wächter im Gehirn: Netzwerk Leben
Groß, M. (2017) · Chemie in unserer Zeit · doi:10.1002/ciuz.201770510
Kata, D. (2017) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.4142 · Cited by 1
European Molecular Biology Organization (EMBO) Workshop: Microglia 2018
Horiuchi, H. (2018) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12468
“In this meeting, Professor Stevens reported that C1q-labeled synapse engulfment by microglia also occurs in a mouse model of AD.12 Oligomeric amyloid beta activates the C1q cascade, inducing phagocytic activity of © 2018 Japanese Society for Neuroimmunology202 Clinical and Experimental Neuroimmunology 9 (2018) 202–204…”
BackgroundFENS ‐Kavli winter symposium: Review and perspectives on neurological diseases
Andreae, L. C. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.14065
“as important for synaptic pruning (Hong et al., 2016).”
Microglial Heterogeneity in a Mouse Model of Alzheimer’s Disease: A Mass Cytometry AnalysisPreprint
Fountain, E. M., Esparza, T., Malkova, O., Oh, S. T., & Brody, D. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/404178
Neuroimmunotoxicology of the heavy metal toxicant lead
Kasten‐Jolly, J., & Lawrence, D. A. (2018) · Advances in neurotoxicology · doi:10.1016/bs.ant.2018.10.004 · Cited by 1
Choi, H., Choi, Y., Hwang, D. W., & Lee, D. S. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/522987
“suggested the synaptic loss in the AD mouse model according to the microglial activation and complement-mediated immune reaction (16).”
MethodStower, H., Bondar, T., Farrell, A., Basson, M., Levinson, R. S., Borowski, C., Carmona, J. A. D. D., & Benedetti, B. L. (2016) · Nature Medicine · doi:10.1038/nm1216-1374
Bazan, N. G., & Gordon, W. C. (2019) · Neuron · doi:10.1016/j.neuron.2019.02.004
Brenner, S. R. (2019) · OBM Geriatrics · doi:10.21926/obm.geriatr.1901035
Microglia subtype and brain functions
Tanabe, S., & Muramatsu, R. (2019) · Folia Pharmacologica Japonica · doi:10.1254/fpj.153.199
Mucosal Macrophage Polarization Role in the Immune Modulation
Wu, T., Chen, S., & Wu, Y. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.86609
Sanchez, J. J. (2019) · UNM’s Digital Repository (University of New Mexico)
The Role of Interleukin-10 in CD4+ T Cell-Mediated Neuroprotection after Facial Nerve Injury
Runge, E. M. (2019) · IUScholarWorks (Indiana University) · doi:10.7912/c2/2118
Toxoplasma induces stripping of perisomatic inhibitory synapsesPreprint
Carrillo, G. L., Ballard, V. A., Glausen, T. G., Boone, Z., Teamer, J., Hinkson, C. L., Wohlfert, E. A., Blader, I. J., & Fox, M. A. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/788190
“In cases where microglia have been implicated in the pathological loss of synapses, it appears to be mediated through the complement pathway (Hong et al. 2016; Sekar et al. 2016; Vasek et al. 2016; Hammond et al. BioRxiv), a similar pathway used to prune the excess of excitatory synapses during…”
BackgroundMethod‘Non-self’ mutation in a Drosophila model of expanded CAG repeat neurodegenerative disease
Scott, A. W. (2019) · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
Sepulveda‐Rodriguez, A. (2019) · DigitalGeorgetown (Georgetown University Library)
The effect of irrelevant visual experience on visual memory
Indulkar, S. S. (2019) · KU ScholarWorks (The University of Kansas)
Wang, G., Yin, W., Shin, H., & Hou, X. S. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.27.012526
“However, the increased activated microglia were not colocalized with the lysosomal protein CD68 (Figure S4h), indicating that they were not activated to engulf synaptic material as previously described in Alzheimer mouse models (Hong et al., 2016).”
BackgroundStudy of pre-synaptic internalisation in human schizophrenia brainsPreprint
Tzioras, M., Stevenson, A. J., Boche, D., & Spires‐Jones, T. L. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.22.110759
Effects of anle138b treatment on amyloid-β neurotoxicity
Thomas, C. (2020) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-8233
Metadata
- Authors
- Hong, S., Beja-Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K. M., Shi, Q., Rosenthal, A., Barres, B. A., Lemere, C. A., Selkoe, D. J., & Stevens, B.
- Affiliations
- Boston Children's Hospital (US)
- Brigham and Women's Hospital (US)
- University of California, San Francisco (US)
- Stanford Medicine (US)
- Broad Institute (US)
- Corresponding author
- Beja-Glasser, Victoria F.
- Nfonoyim, Bianca M.
- Stevens, Beth
- ORCID
- Venue
- Science
- Published
- 2016-05-06
- Volume
- 352
- Issue
- 6286
- Pages
- 712-716
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC5094372
- OpenAlex
- W2314634699
- Cited by
- 3,343
- References
- 33
- Citations by year
- 2026: 415 · 2025: 391 · 2024: 384 · 2023: 388 · 2022: 324 · 2021: 363 · 2020: 306 · 2019: 260 · 2018: 240 · 2017: 198 · 2016: 69
- FWCI
- 140.04
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Edward R. and Anne G. Lefler Fellowship
- Coins for Alzheimer's Research Trust
- Fidelity Biosciences Research Initiative
- JPB Foundation
- National Institutes of Health (AG000222)
- National Institute of Neurological Disorders and Stroke-NIH (R01NS083845)
- National Institute on Aging-NIH (1RF1AG051496A)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- Alzheimer's disease, synaptic loss, complement system, microglia, C1q, CR3, complement C3, soluble amyloid-beta oligomers, neuroinflammation, synaptic pruning, hippocampal long-term potentiation, phagocytosis, mouse model
- MeSH terms
- Disks Large Homolog 4 Protein, Alzheimer Disease, Animals, Cognition Disorders, Complement Pathway, Classical, Disease Models, Animal, Membrane Proteins, Phagocytosis, Synapses, Up-Regulation, Complement C1q, Macrophage-1 Antigen, Amyloid beta-Peptides, Synaptophysin, Microglia, Long-Term Potentiation, Mice, Knockout, Mice, Guanylate Kinases, CA1 Region, Hippocampal, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.